The drug is used to treat cystic fibrosis patients with P. aeruginosa.
Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about the development.
Share prices of Lupin rose 1.58 per cent to close at Rs1,490 on the Bombay Stock Exchange on Thursday, while the benchmark Sensex ended 0.56 per cent higher.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.